Literature DB >> 28225165

The contrasting roles of Th17 immunity in human health and disease.

Edwin Hoe1, Jeremy Anderson1, Jordan Nathanielsz1, Zheng Quan Toh1, Rachel Marimla1, Anne Balloch1, Paul V Licciardi1,2.   

Abstract

The human immune system is a tightly regulated network that protects the host from disease. An important aspect of this is the balance between pro-inflammatory Th17 cells and anti-inflammatory T regulatory (Treg) cells in maintaining immune homeostasis. Foxp3+ Treg are critical for sustaining immune tolerance through IL-10 and transforming growth factor-β while related orphan receptor-γt+ Th17 cells promote immunopathology and auto-inflammatory diseases through the actions of IL-17A, IL-21 and IL-22. Therefore, imbalance between Treg and Th17 cells can result in serious pathology in many organs and tissues. Recently, certain IL-17-producing cells have been found to be protective against infectious disease, particularly in relation to extracellular bacteria such Streptococcus pneumoniae; a number of other novel IL-17-secreting cell populations have also been reported to protect against a variety of other pathogens. In this mini-review, the dual roles of Treg and Th17 cells are discussed in the context of autoimmunity and infections, highlighting recent advances in the field. Development of novel strategies specifically designed to target these critical immune response pathways will become increasingly important in maintenance of human health.
© 2017 The Societies and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  autoimmune; infection; inflammation; pneumococcal

Mesh:

Substances:

Year:  2017        PMID: 28225165     DOI: 10.1111/1348-0421.12471

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  16 in total

1.  Comparison of specific in-vitro virulence gene expression and innate host response in locally invasive vs colonizer strains of Streptococcus pneumoniae.

Authors:  Naoko Fuji; Michael E Pichichero; Ravinder Kaur
Journal:  Med Microbiol Immunol       Date:  2021-03-22       Impact factor: 3.402

Review 2.  Immunodeficiency in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Sheling Xie; Kaifei Wang; Wei Zhang; Kun Xiao; Peng Yan; Yanqin Li; Wanxue He; Yuhan Zhang; Lixin Xie
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

3.  Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease.

Authors:  Ju Mi Lee; Jiyun Park; Steven G Reed; Rhea N Coler; Jung Joo Hong; Lee-Han Kim; Wonsik Lee; Kee Woong Kwon; Sung Jae Shin
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

4.  Th17 cell plasticity towards a T-bet-dependent Th1 phenotype is required for bacterial control in Staphylococcus aureus infection.

Authors:  Patricia Bartsch; Christoph Kilian; Malte Hellmig; Hans-Joachim Paust; Alina Borchers; Amirrtavarshni Sivayoganathan; Leon Enk; Yu Zhao; Nikhat Shaikh; Henning Büttner; Milagros N Wong; Victor G Puelles; Thorsten Wiech; Richard Flavell; Tobias B Huber; Jan-Eric Turner; Stefan Bonn; Samuel Huber; Nicola Gagliani; Hans-Willi Mittrücker; Holger Rohde; Ulf Panzer; Christian F Krebs
Journal:  PLoS Pathog       Date:  2022-04-21       Impact factor: 6.823

5.  The Human Penis Is a Genuine Immunological Effector Site.

Authors:  Alexis Sennepin; Fernando Real; Marine Duvivier; Yonatan Ganor; Sonia Henry; Diane Damotte; Marc Revol; Sonia Cristofari; Morgane Bomsel
Journal:  Front Immunol       Date:  2017-12-14       Impact factor: 7.561

6.  Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Guérin Russia Vaccination.

Authors:  Fatoumatta Darboe; Jane U Adetifa; John Reynolds; Safayet Hossin; Magdalena Plebanski; Mihai G Netea; Sarah L Rowland-Jones; Jayne S Sutherland; Katie L Flanagan
Journal:  Front Immunol       Date:  2017-09-08       Impact factor: 7.561

Review 7.  The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2).

Authors:  Narasimha M Beeraka; SubbaRao V Tulimilli; Medha Karnik; Surya P Sadhu; Rajeswara Rao Pragada; Gjumrakch Aliev; SubbaRao V Madhunapantula
Journal:  Biomed Res Int       Date:  2021-06-01       Impact factor: 3.411

8.  Different T cell related immunological profiles in COVID-19 patients compared to healthy controls.

Authors:  Armin Mahmoud Salehi Khesht; Vahid Karpisheh; Balsam Qubais Saeed; Angelina Olegovna Zekiy; Lis M Yapanto; Mohsen Nabi Afjadi; Mohsen Aksoun; Maryam Nasr Esfahani; Fatemeh Aghakhani; Mahsa Movahed; Navneet Joshi; Kazem Abbaszadeh-Goudarzi; Shahin Hallaj; Majid Ahmadi; Sanam Dolati; Ata Mahmoodpoor; Vida Hashemi; Farhad Jadidi-Niaragh
Journal:  Int Immunopharmacol       Date:  2021-05-28       Impact factor: 5.714

9.  Evaluating Functional Immunity Following Encapsulated Bacterial Infection and Vaccination.

Authors:  Zheng Quan Toh; Rachel A Higgins; Nadia Mazarakis; Elysia Abbott; Jordan Nathanielsz; Anne Balloch; Kim Mulholland; Paul V Licciardi
Journal:  Vaccines (Basel)       Date:  2021-06-20

Review 10.  IL-33/IL-31 Axis: A Potential Inflammatory Pathway.

Authors:  Eleonora Di Salvo; Elvira Ventura-Spagnolo; Marco Casciaro; Michele Navarra; Sebastiano Gangemi
Journal:  Mediators Inflamm       Date:  2018-03-11       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.